Global Blood Screening Market Size Study, by Technology (NAT, Rapid Test, Western Blot Assay, NGS) by Product & Service (Reagents & Kits, Instruments, Software & Services) by End Use (Blood Banks, Hospitals) by Regional Forecasts 2017-2025

April 2018 | 120 pages | ID: G1BDB0C9719EN
Bizwit Research & Consulting LLP

Abstracts

Global Blood Screening Market valued approximately USD 1.76 million in 2016 is anticipated to grow with a healthy growth rate of more than 9.7 % over the forecast period 2017-2025.Initiatives by the various organizations and governments increase awareness about donation and screening before transfusion. According to the WHO, approximately 108 million blood donations are collected every year across the globe. About 50% of these blood donations collected from high-income countries which is home to less than 20% of the total population. Hence, rising awareness coupled with the high demand for safe blood create opportunities in emerging countries. Growing numbers of blood donations and blood donors with growing consciousness about preserving donated blood and growing occurrence of transferable illnesses, growing call for donated blood, rise in spending on fitness, technical developments in blood screening, growing alertness for fitness and increasing number of initiatives by many administrations and government associations are a few important issues motivating the development of the global blood screening market size. Yet, composite controlling outlines for sanction, shortage of expert manpower, existence of another know-how like digital immunoassay associated with high original investment expenditure and operative costs of testing are the limiting issues for the development of the global blood screening market size.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Technology:

• Nucleic Acid Test (NAT)
• Transcription-Medication Amplification (TMA)
• Real-Time Polymerase Chain Reaction (PCR)
• Rapid Test
• Western Blot Assay
• Next-Generation Sequencing (NGS)

By Product & Services:

• Reagents & Kits
• Instruments
• Software & Service

By End Use:

• Blood Bank
• Hospitals

By Regions:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• Asia Pacific
• China
• India
• Japan
• Latin America
• Brazil
• Mexico
• Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2015
Base year – 2016
Forecast period – 2017 to 2025

Some of the key manufacturers involved in the market are Grifols, F. Hoffmann-La Roche, Abbott Laboratories, Biomerieux, Bio-Rad Laboratories, Inc. Acquisitions and effective mergers are some of the strategies adopted by the key manufacturers. New product launches and continuous technological innovations are the key strategies adopted by the major players.

Target Audience of the Global Blood Screening Market in Market Study:

• Key Consulting Companies & Advisors
• Large, medium-sized, and small enterprises
• Venture capitalists
• Value-Added Resellers (VARs)
• Third-party knowledge providers
• Investment bankers
• Investors

Contents

CHAPTER 1. GLOBAL BLOOD SCREENING MARKET DEFINITION AND SCOPE

1.1. Research Objective
1.2. Market Definition
1.3. Scope of The Study
1.4. Years Considered for The Study
1.5. Currency Conversion Rates
1.6. Report Limitation

CHAPTER 2. RESEARCH METHODOLOGY

2.1. Research Process
  2.1.1. Data Mining
  2.1.2. Analysis
  2.1.3. Market Estimation
  2.1.4. Validation
  2.1.5. Publishing
2.2. Research Assumption

CHAPTER 3. EXECUTIVE SUMMARY

3.1. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
3.2. Key Trends

CHAPTER 4. GLOBAL BLOOD SCREENING MARKET DYNAMICS

4.1. Growth Prospects
  4.1.1. Drivers
  4.1.2. Restraints
  4.1.3. Opportunities
4.2. Industry Analysis
  4.2.1. Porter’s 5 Force Model
  4.2.2. PEST Analysis
  4.2.3. Value Chain Analysis
4.3. Analyst Recommendation & Conclusion

CHAPTER 5. GLOBAL BLOOD SCREENING MARKET, BY TECHNOLOGY

5.1. Market Snapshot
5.2. Market Performance - Potential Model
5.3. Global Blood Screening Market, Sub Segment Analysis
  5.3.1. Nucleic Acid Test (NAT)
  5.3.2. Rapid Test
  5.3.3. Western Blot Assay
  5.3.4. Next-Generation Sequencing (NGS)

CHAPTER 6. GLOBAL BLOOD SCREENING MARKET, BY PRODUCT & SERVICES

6.1. Market Snapshot
6.2. Market Performance - Potential Model
6.3. Global Blood Screening Market, Sub Segment Analysis
  6.3.1. Reagents & Kits
    6.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    6.3.1.3. Reagents & Kits Sub Segments breakdown estimates & forecasts, 2015-2025 (USD Billion)
      6.3.1.3.1. NAT Reagents & Kits
      6.3.1.3.2. ELISA Reagents & Kits
      6.3.1.3.3. Other Reagents
  6.3.2. Instruments
    6.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    6.3.2.3. Instruments Sub Segments breakdown estimates & forecast, 2015-2025 (USD Billion)
      6.3.2.3.1. Rental Purchase
      6.3.2.3.2. Outright Purchase
  6.3.3. Software & Service
    6.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

CHAPTER 7. GLOBAL BLOOD SCREENING MARKET, BY END USE

7.1. Market Snapshot
7.2. Market Performance - Potential Model
7.3. Global Blood Screening Market, Sub Segment Analysis
  7.3.1. Blood Bank
    7.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  7.3.2. Hospital
    7.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

CHAPTER 8. GLOBAL BLOOD SCREENING MARKET, BY REGIONAL ANALYSIS

8.1. Blood Screening Market, Regional Market Snapshot (2015-2025)
8.2. North America Blood Screening Market Snapshot
  8.2.1. U.S.
    8.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.2.1.2. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.2.1.3. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.2.1.4. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.2.2. Canada
    8.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.2.2.2. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.2.2.3. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.2.2.4. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3. Europe Blood Screening Market Snapshot
  8.3.1. U.K.
    8.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.3.1.2. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.1.3. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.1.4. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.3.2. Germany
    8.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.3.2.2. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.2.3. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.2.4. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.3.3. France
    8.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.3.3.2. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.3.3. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.3.4. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.3.4. Rest of Europe
    8.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.3.4.2. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.4.3. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.4.4. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4. Asia Blood Screening Market Snapshot
  8.4.1. China
    8.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.4.1.2. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.1.3. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.1.4. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.4.2. India
    8.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.4.2.2. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.2.3. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.2.4. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.4.3. Japan
    8.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.4.3.2. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.3.3. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.3.4. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.4.4. Rest of Asia Pacific
    8.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.4.4.2. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.4.3. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.4.4. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.5. Latin America Blood Screening Market Snapshot
  8.5.1. Brazil
    8.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.5.1.2. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.5.1.3. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.5.1.4. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.5.2. Mexico
    8.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.5.2.2. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.5.2.3. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.5.2.4. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.6. Rest of The World
  8.6.1. South America
    8.6.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.6.1.2. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.6.1.3. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.6.1.4. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.6.2. Middle East and Africa
    8.6.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.6.2.2. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.6.2.3. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.6.2.4. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

CHAPTER 9. COMPETITIVE INTELLIGENCE

9.1. Company Market Share (Subject to Data Availability)
9.2. Top Market Strategies
9.3. Company Profiles
  9.3.1. Grifols
    9.3.1.1. Overview
    9.3.1.2. Financial (Subject to Data Availability)
    9.3.1.3. Product Summary
    9.3.1.4. Recent Developments
  9.3.2. F. Hoffmann-La Roche
  9.3.3. Abbott Laboratories
  9.3.4. Biomerieux
  9.3.5. Bio-Rad Laboratories, Inc.
  9.3.6. Siemens Healthineers
  9.3.7. Ortho Clinical Diagnostics, Inc.
  9.3.8. Thermo Fisher Scientific, Inc.
  9.3.9. Beckman Coulter
  9.3.10. Becton, Dickinson & Company